Class IIOngoing

Trinity Gold Nutrition recall

FDA recall D-0042-2025 · initiated Nov 6, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.

Details

Product: Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009
Recalling company: Trinity Gold Nutrition
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide within the United States; additionally Canada, England, and Australia.
Initiated: Nov 6, 2024
FDA report date: Nov 20, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0042-2025 ↗

← All drug recalls